Yu‐Min Yeh

1000 total citations
35 papers, 215 citations indexed

About

Yu‐Min Yeh is a scholar working on Oncology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Yu‐Min Yeh has authored 35 papers receiving a total of 215 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 8 papers in Molecular Biology and 8 papers in Pathology and Forensic Medicine. Recurrent topics in Yu‐Min Yeh's work include Colorectal Cancer Treatments and Studies (8 papers), Cancer Genomics and Diagnostics (6 papers) and Genetic factors in colorectal cancer (6 papers). Yu‐Min Yeh is often cited by papers focused on Colorectal Cancer Treatments and Studies (8 papers), Cancer Genomics and Diagnostics (6 papers) and Genetic factors in colorectal cancer (6 papers). Yu‐Min Yeh collaborates with scholars based in Taiwan, United States and Australia. Yu‐Min Yeh's co-authors include Peng‐Chan Lin, Meng-Ru Shen, Shang‐Hung Chen, Yaping Chen, Po-Chuan Chen, Wu‐Chou Su, Tsai‐Yun Chen, Shang‐Yin Wu, Bo‐Wen Lin and Po-Yan Tseng and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Yu‐Min Yeh

30 papers receiving 214 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yu‐Min Yeh Taiwan 10 79 75 40 35 29 35 215
Luca Paruzzo Italy 6 99 1.3× 71 0.9× 58 1.4× 33 0.9× 14 0.5× 12 192
Tupitsyn Nn Russia 7 87 1.1× 43 0.6× 21 0.5× 21 0.6× 46 1.6× 74 195
Thomas Negele Germany 10 107 1.4× 114 1.5× 72 1.8× 25 0.7× 21 0.7× 17 460
Jennifer Kherani United States 10 113 1.4× 65 0.9× 23 0.6× 104 3.0× 10 0.3× 19 241
Catherine Gutierrez United States 8 54 0.7× 86 1.1× 38 0.9× 35 1.0× 9 0.3× 15 239
Qiaodan Liu China 10 92 1.2× 85 1.1× 17 0.4× 74 2.1× 7 0.2× 25 250
David Kaminetzky United States 8 111 1.4× 157 2.1× 15 0.4× 62 1.8× 58 2.0× 20 303
Koichi Onodera Japan 11 67 0.8× 63 0.8× 16 0.4× 30 0.9× 79 2.7× 38 264
Wenliang Li China 8 124 1.6× 68 0.9× 21 0.5× 53 1.5× 5 0.2× 21 237
Sara Delfanti Italy 10 116 1.5× 58 0.8× 17 0.4× 95 2.7× 7 0.2× 32 254

Countries citing papers authored by Yu‐Min Yeh

Since Specialization
Citations

This map shows the geographic impact of Yu‐Min Yeh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu‐Min Yeh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu‐Min Yeh more than expected).

Fields of papers citing papers by Yu‐Min Yeh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu‐Min Yeh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu‐Min Yeh. The network helps show where Yu‐Min Yeh may publish in the future.

Co-authorship network of co-authors of Yu‐Min Yeh

This figure shows the co-authorship network connecting the top 25 collaborators of Yu‐Min Yeh. A scholar is included among the top collaborators of Yu‐Min Yeh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu‐Min Yeh. Yu‐Min Yeh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tseng, Po-Yan & Yu‐Min Yeh. (2025). Phenomenology of neutrino-dark matter interaction in DSNB and AGN. Journal of Cosmology and Astroparticle Physics. 2025(8). 38–38. 1 indexed citations
2.
Sun, Yuan‐Ting, Ming‐Hui Chang, Shu-Wei Huang, et al.. (2025). Promoter demethylation and protein O-GlcNAcylation-mediated enhancement of fatty acid synthase contributes to hepatic steatosis and inflammation in MASLD. The Journal of Nutritional Biochemistry. 150. 110227–110227. 1 indexed citations
3.
Chen, Chung‐Hsing, Yu‐Min Yeh, Peng-Chan Lin, et al.. (2025). Cathepsin S regulates antitumor immunity through autophagic degradation of PD-L1 in colorectal cancer cells. Cancer Immunology Immunotherapy. 74(9). 287–287. 1 indexed citations
4.
Hsu, Ya‐Ting, Pei‐Ying Wu, Yu‐Min Yeh, et al.. (2024). Tight junction protein cingulin variant is associated with cancer susceptibility by overexpressed IQGAP1 and Rac1-dependent epithelial-mesenchymal transition. Journal of Experimental & Clinical Cancer Research. 43(1). 65–65. 6 indexed citations
6.
Su, Wu‐Chou, Li‐Yuan Bai, Hui‐Hua Hsiao, et al.. (2024). Abstract CT167: Trial in progress: Phase 1 dose escalation study of T-1101, a first-in-class oral Hec1/Nek2 inhibitor, in patients with advanced refractory solid tumors. Cancer Research. 84(7_Supplement). CT167–CT167. 1 indexed citations
7.
Cheng, Jordan, Feng Li, Chien‐Chung Lin, et al.. (2023). Distinct Features of Plasma Ultrashort Single-Stranded Cell-Free DNA as Biomarkers for Lung Cancer Detection. Clinical Chemistry. 69(11). 1270–1282. 5 indexed citations
12.
Yeh, Yu‐Min, Pei‐Fang Su, Bo-Wen Lin, et al.. (2022). HER2 amplification in colorectal cancer with brain metastasis: A propensity score matching study. European Journal of Cancer. 181. 62–69. 16 indexed citations
13.
Lin, Peng‐Chan, et al.. (2022). Cutting-Edge AI Technologies Meet Precision Medicine to Improve Cancer Care. Biomolecules. 12(8). 1133–1133. 12 indexed citations
14.
Lin, Peng‐Chan, Shang‐Yin Wu, Bo‐Wen Lin, et al.. (2022). PD-L1 Expression in High-Risk Early-Stage Colorectal Cancer—Its Clinical and Biological Significance in Immune Microenvironment. International Journal of Molecular Sciences. 23(21). 13277–13277. 12 indexed citations
15.
Chen, Po-Chuan, Yu‐Min Yeh, Bo‐Wen Lin, et al.. (2022). The Expression Quantitative Trait Loci in Immune Response Genes Impact the Characteristics and Survival of Colorectal Cancer. Diagnostics. 12(2). 315–315. 4 indexed citations
16.
Liaw, Hungjiun, Nai‐Jung Chiang, Shang‐Hung Chen, et al.. (2022). CHK2 activation contributes to the development of oxaliplatin resistance in colorectal cancer. British Journal of Cancer. 127(9). 1615–1628. 19 indexed citations
17.
Yeh, Yu‐Min, Peng‐Chan Lin, Wu‐Chou Su, & Meng-Ru Shen. (2021). CD40 Pathway and IL-2 Expression Mediate the Differential Outcome of Colorectal Cancer Patients with Different CSF1R c.1085 Genotypes. International Journal of Molecular Sciences. 22(22). 12565–12565. 6 indexed citations
18.
Yeh, Yu‐Min, Shang‐Hung Chen, Yilin Chen, et al.. (2019). <p>Comprehensive assessment of <em>HER2</em> alteration in a colorectal cancer cohort: from next-generation sequencing to clinical significance</p>. Cancer Management and Research. Volume 11. 7867–7875. 7 indexed citations
19.
Wu, Shang‐Yin, Yu‐Min Yeh, Yaping Chen, Wu‐Chou Su, & Tsai‐Yun Chen. (2012). Low incidence of thromboembolism in relapsed/refractory myeloma patients treated with thalidomide without thromboprophylaxis in Taiwan. Annals of Hematology. 91(11). 1773–1778. 18 indexed citations
20.
Yeh, Yu‐Min, Kung‐Chao Chang, Yaping Chen, et al.. (2010). Large B cell lymphoma presenting initially in bone marrow, liver and spleen: an aggressive entity associated frequently with haemophagocytic syndrome. Histopathology. 57(6). 785–795. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026